Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Medicines and Healthcare products Regulatory Agency on reducing overprescribing.

I have discussed with the Medicines and Healthcare products Regulatory Agency (MHRA) concerns raised by Members of Parliament about the adverse effects of antidepressant prescribing, and what the MHRA can do to improve communication on the risks of different medicines.